Related references
Note: Only part of the references are listed.Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana
Rebecca Zash et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Birth Defects After Exposure to Efavirenz-Based Antiretroviral Therapy at Conception/First Trimester of Pregnancy: A Multicohort Analysis
Begona Martinez de Tejada et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2019)
Does Changing Antiretroviral Therapy in the First Trimester of Pregnancy for Safety Concerns Have an Impact on Viral Suppression?
Violaine Peyronnet et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2019)
Cobicistat-containing antiretroviral regimens are not recommended during pregnancy: viewpoint
Sarita D. Boyd et al.
AIDS (2019)
Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum
Ahizechukwu C. Eke et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2018)
Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study
Olayemi Osiyemi et al.
INFECTIOUS DISEASES AND THERAPY (2018)
Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy
Rebecca Zash et al.
JAMA PEDIATRICS (2017)
Lowered Rilpivirine Exposure During the Third Trimester of Pregnancy in Human Immunodeficiency Virus Type 1-Infected Women
Stein Schalkwijk et al.
CLINICAL INFECTIOUS DISEASES (2017)
Risk of cancer in children exposed to didanosine in utero
Mira Hleyhel et al.
AIDS (2016)
Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women
Anna H. Tran et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
M. G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Association between Prenatal Exposure to Antiretroviral Therapy and Birth Defects: An Analysis of the French Perinatal Cohort Study (ANRS CO1/CO11)
Jeanne Sibiude et al.
PLOS MEDICINE (2014)
Premature Delivery in HIV-Infected Women Starting Protease Inhibitor Therapy During Pregnancy: Role of the Ritonavir Boost?
Jeanne Sibiude et al.
CLINICAL INFECTIOUS DISEASES (2012)
Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007
Claire L. Townsend et al.
AIDS (2009)
Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS french perinatal cohort
Josiane Warszawski et al.
AIDS (2008)
Share Paper
